Overview

The Repatriation Medical Authority Instrument No. 87 of 2007 amends Instrument No. 17 of 2006, concerning malignant neoplasm of the lung, under the Veterans' Entitlements Act 1986. This instrument addresses the need to revise the definition of 'a substance from the specified list' in the 2006 instrument, reflecting the legislative intent to provide clarity and precision in the conditions pertaining to veterans’ entitlements for lung cancer. Enacted under the authority granted by subsection 196B(2) and (8) of the VEA, the instrument is aimed at ensuring the ongoing accuracy and relevance of the legislative framework governing veterans' health claims. The Authority advertised its intention to investigate and revise the Statement of Principles in the Government Notices Gazette, inviting submissions from relevant parties, though none were received. The amendment was finalised following the investigation, which was publicised in the Gazette of 2 May 2007.

Scope and Application

This legislation pertains to Instrument No. 87 of 2007, which amends the previous Instrument No. 17 of 2006 concerning the Statement of Principles related to malignant neoplasm of the lung. The Veterans’ Entitlements Act 1986 and the Military Rehabilitation and Compensation Act 2004 form the legislative framework for this amendment. The Repatriation Medical Authority, established under these acts, is responsible for determining such instruments, which are intended to assist in the assessment of claims by veterans and their dependants for medical conditions arising from their service. The application of this specific instrument is directed towards veterans and their dependants who may be suffering from malignant neoplasm of the lung, seeking to refine the criteria for recognition of this condition as service-related. The authority’s determination is effective nationally, encompassing all states and territories within Australia, and applies to claims made under the specified acts. The instrument does not exclude any particular group or entity but rather adjusts the criteria to better align with the evidence and understanding of the condition as it affects veterans. The exclusions or thresholds for eligibility are defined within the amended clauses of the instrument, which now more precisely define what constitutes 'a substance from the specified list'. This instrument, while finalising the investigation into malignant neoplasm of the lung, allows for potential further amendments through subordinate instruments if new evidence or considerations arise.

Key Provisions

The main operative sections of the Repatriation Medical Authority Instrument No. 87 of 2007 involve amendments to the Statement of Principles concerning malignant neoplasm of the lung, as set out in Instrument No. 17 of 2006. Specifically, section 2 of the Instrument amends the definition of 'a substance from the specified list' in clause 9 of Instrument No. 17 of 2006. This amendment seeks to refine the criteria for determining when malignant neoplasm of the lung in veterans may be attributable to service-related factors, particularly concerning exposure to substances from the specified list. The changes are designed to more accurately reflect the circumstances under which these conditions may arise and to ensure that veterans receive appropriate consideration for their entitlements. The obligations and requirements imposed by this Instrument on the parties it governs are primarily centred around the reassessment of claims related to malignant neoplasm of the lung. The Repatriation Medical Authority is tasked with ensuring that the new definition of 'a substance from the specified list' is applied consistently and fairly when evaluating claims. This involves reviewing existing cases and applying the amended criteria to determine whether new entitlements may be granted or existing entitlements adjusted. Additionally, the Authority must communicate these changes to relevant stakeholders, including veterans, service personnel, and their representatives, to ensure transparency and understanding of the amended criteria. In terms of potential offences, penalties, or consequences for breach, the Instrument itself does not specify any new criminal or civil penalties. However, the underlying Acts, namely the Veterans’ Entitlements Act 1986 and the Military Rehabilitation and Compensation Act 2004, do contain provisions for offences and penalties related to fraudulent claims or misrepresentation of facts. For example, section 196I of the Veterans’ Entitlements Act 1986 imposes penalties for providing false or misleading information in the context of entitlements, with penalties that can include fines and imprisonment. The maximum penalties for such offences can be significant, reflecting the seriousness with which the law regards fraudulent activities in the administration of veterans’ benefits. Given the nature of the amendments in Instrument No. 87 of 2007, the primary consequence of non-compliance would be the potential for claims to be denied or adjusted in accordance with the revised criteria. Veterans or their representatives who believe that the new definitions unfairly affect their eligibility for benefits may seek review or appeal of decisions made under the amended criteria. The process for such reviews is governed by the provisions of the Veterans’ Entitlements Act 1986 and the Military Rehabilitation and Compensation Act 2004, which provide mechanisms for internal review and external appeal to the Administrative Appeals Tribunal.